JP2023524207A5 - - Google Patents
Info
- Publication number
- JP2023524207A5 JP2023524207A5 JP2022564532A JP2022564532A JP2023524207A5 JP 2023524207 A5 JP2023524207 A5 JP 2023524207A5 JP 2022564532 A JP2022564532 A JP 2022564532A JP 2022564532 A JP2022564532 A JP 2022564532A JP 2023524207 A5 JP2023524207 A5 JP 2023524207A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- alkyl
- cycloalkyl
- optionally substituted
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2005852.5A GB202005852D0 (en) | 2020-04-22 | 2020-04-22 | Therapeutic compounds |
| GB2005852.5 | 2020-04-22 | ||
| PCT/GB2021/050975 WO2021214472A1 (en) | 2020-04-22 | 2021-04-22 | Tetrahydroisoquinoline compounds as nrf2 activators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524207A JP2023524207A (ja) | 2023-06-09 |
| JP2023524207A5 true JP2023524207A5 (enExample) | 2024-04-09 |
| JP7751165B2 JP7751165B2 (ja) | 2025-10-08 |
Family
ID=70859963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564532A Active JP7751165B2 (ja) | 2020-04-22 | 2021-04-22 | Ｎｒｆ２活性化剤としてのテトラヒドロイソキノリン化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20230159511A1 (enExample) |
| EP (1) | EP4139295B1 (enExample) |
| JP (1) | JP7751165B2 (enExample) |
| KR (1) | KR20230004722A (enExample) |
| CN (1) | CN115667242B (enExample) |
| AR (1) | AR121913A1 (enExample) |
| AU (1) | AU2021258539A1 (enExample) |
| BR (1) | BR112022021370A2 (enExample) |
| CA (1) | CA3174360A1 (enExample) |
| ES (1) | ES3031970T3 (enExample) |
| GB (1) | GB202005852D0 (enExample) |
| IL (1) | IL297440A (enExample) |
| MX (1) | MX2022013396A (enExample) |
| PH (1) | PH12022552773A1 (enExample) |
| WO (1) | WO2021214472A1 (enExample) |
| ZA (1) | ZA202211464B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS64836B1 (sr) | 2018-10-22 | 2023-12-29 | C4X Discovery Ltd | Terapijska jedinjenja |
| JP2024542974A (ja) | 2021-10-25 | 2024-11-19 | シーフォーエックス・ディスカバリー・リミテッド | Ｋｅａｐ１結合剤であるテトラヒドロイソキノリン化合物 |
| AU2023204960A1 (en) * | 2022-01-07 | 2024-05-16 | Chugai Seiyaku Kabushiki Kaisha | Nitrogen-containing heterocyclic compound having nrf2 activation effect |
| WO2024130411A1 (en) * | 2022-12-21 | 2024-06-27 | Variational Ai Inc. | Protease inhibitors and methods of using same |
| EP4696692A1 (en) * | 2023-06-19 | 2026-02-18 | Chugai Seiyaku Kabushiki Kaisha | Crystal of nitrogen-containing heterocyclic compound having nrf2 activation effect |
| EP4596534A1 (en) * | 2024-01-31 | 2025-08-06 | University of Copenhagen | Noncovalent small-molecule inhibitors of the keap1-nrf2 interaction |
| TW202604491A (zh) | 2024-05-13 | 2026-02-01 | 瑞典商阿斯特捷利康公司 | 用於療法中之ｋｅａｐ１抑制劑 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140256767A1 (en) * | 2011-10-31 | 2014-09-11 | The Broad Institute, Inc. | Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators |
| KR20180017038A (ko) * | 2015-06-15 | 2018-02-20 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Nrf2 조절제 |
| JP2020097526A (ja) * | 2017-03-28 | 2020-06-25 | 武田薬品工業株式会社 | 複素環化合物 |
| RS64836B1 (sr) * | 2018-10-22 | 2023-12-29 | C4X Discovery Ltd | Terapijska jedinjenja |
-
2020
- 2020-04-22 GB GBGB2005852.5A patent/GB202005852D0/en not_active Ceased
-
2021
- 2021-04-22 AU AU2021258539A patent/AU2021258539A1/en active Pending
- 2021-04-22 PH PH1/2022/552773A patent/PH12022552773A1/en unknown
- 2021-04-22 IL IL297440A patent/IL297440A/en unknown
- 2021-04-22 MX MX2022013396A patent/MX2022013396A/es unknown
- 2021-04-22 WO PCT/GB2021/050975 patent/WO2021214472A1/en not_active Ceased
- 2021-04-22 CN CN202180030434.4A patent/CN115667242B/zh active Active
- 2021-04-22 ES ES21724005T patent/ES3031970T3/es active Active
- 2021-04-22 JP JP2022564532A patent/JP7751165B2/ja active Active
- 2021-04-22 KR KR1020227040564A patent/KR20230004722A/ko active Pending
- 2021-04-22 EP EP21724005.0A patent/EP4139295B1/en active Active
- 2021-04-22 CA CA3174360A patent/CA3174360A1/en active Pending
- 2021-04-22 AR ARP210101081A patent/AR121913A1/es unknown
- 2021-04-22 US US17/920,244 patent/US20230159511A1/en active Pending
- 2021-04-22 BR BR112022021370A patent/BR112022021370A2/pt unknown
-
2022
- 2022-10-19 ZA ZA2022/11464A patent/ZA202211464B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11912686B2 (en) | LPA receptor antagonists and uses thereof | |
| US10590113B2 (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists | |
| JP7792915B2 (ja) | Ｃｄ３８阻害薬 | |
| EP2358202B1 (en) | Benzimidazole and aza-benzimidazole carboxamides | |
| US20090239845A1 (en) | Pyrazole compounds as prostaglandin receptors ligands | |
| ES2791340T3 (es) | Derivado de urea o sal farmacológicamente aceptable del mismo | |
| CN113710656B (zh) | 作为法尼醇x受体调节剂的经取代的双环化合物 | |
| HRP20231306T1 (hr) | Terapeutski spojevi | |
| RU2021133444A (ru) | Производные бензимидазола в качестве модуляторов ror-гамма | |
| US8367679B2 (en) | Biaryl carboxamides | |
| EP3303330A1 (en) | 4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders | |
| JP2011500563A (ja) | ジフェニル置換されたシクロアルカン | |
| JP2024525900A (ja) | グルカゴン様ペプチド－１受容体モジュレーター及びその使用 | |
| EP3704106A1 (en) | Alkene compounds as farnesoid x receptor modulators | |
| US20170197953A1 (en) | FACTOR XIa INHIBITORS | |
| US20100056527A1 (en) | Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor | |
| JP2023524206A5 (enExample) | ||
| US12344597B2 (en) | Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosis | |
| EP2888244A1 (en) | Novel pyridine derivatives | |
| TWI881587B (zh) | 類木瓜蛋白酶(PLpro)抑制劑 | |
| EA047337B1 (ru) | Замещенные бициклические соединения в качестве модуляторов фарнезоидного х-рецептора | |
| EA040901B1 (ru) | Алкокси-замещенные пиридинильные производные в качестве антагонистов рецепторов lpa1 и их применение для лечения фиброза | |
| HK1232215B (zh) | 作为醛固酮合酶抑制剂的新型二氢喹啉吡唑基化合物 |